Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT
Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT
Recruiting · NCT06130579 · Registry updated 2025-06-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, bone marrow disorder, hematologic disorder, leukemia, myelodysplastic syndrome, myeloid leukemia, neoplasm | Recruiting | Phase 2 | 2025-06-03 | NCT06130579 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Peking University People's Hospital | 269 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Deparment of Hematology, Peking University People's Hospital | Beijing | China | 2 |